Patents by Inventor Maurizio Paolo Maria FEDERICO

Maurizio Paolo Maria FEDERICO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NUCLEOTIDE SEQUENCE EXPRESSING AN EXOSOME-ANCHORING PROTEIN FOR USE AS VACCINE
    Publication number: 20230364211
    Abstract: The present invention concerns a nucleotide sequence expressing a fusion protein, said fusion protein comprising or consisting of an exosome-anchoring protein fused at its C-terminus with an antigen, or a DNA expression vector comprising said nucleotide sequence, for use as vaccine.
    Type: Application
    Filed: January 20, 2023
    Publication date: November 16, 2023
    Applicant: ISTITUTO SUPERIORE DI SANITÀ
    Inventor: Maurizio Paolo Maria FEDERICO
  • EXOSOME-ANCHORING FUSION PROTEINS AND VACCINES
    Publication number: 20230173063
    Abstract: Provided herein are exosome-anchoring fusion proteins and methods of using the exosome-anchoring fusion proteins for immunization to treat or prevent diseases such as virus infections or cancer.
    Type: Application
    Filed: May 4, 2021
    Publication date: June 8, 2023
    Inventors: Cristina PELIZON, Maurizio Paolo Maria FEDERICO
  • Nucleotide sequence expressing an exosome-anchoring protein for use as vaccine
    Patent number: 11559571
    Abstract: The present invention concerns a nucleotide sequence expressing a fusion protein, said fusion protein comprising or consisting of an exosome-anchoring protein fused at its C-terminus with an antigen, or a DNA expression vector comprising said nucleotide sequence, for use as vaccine.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: January 24, 2023
    Assignee: ISTITUTO SUPERIORS DI SANITÀ
    Inventor: Maurizio Paolo Maria Federico
  • NUCLEOTIDE SEQUENCE EXPRESSING AN EXOSOME-ANCHORING PROTEIN FOR USE AS VACCINE
    Publication number: 20200206329
    Abstract: The present invention concerns a nucleotide sequence expressing a fusion protein, said fusion protein comprising or consisting of an exosome-anchoring protein fused at its C-terminus with an antigen, or a DNA expression vector comprising said nucleotide sequence, for use as vaccine.
    Type: Application
    Filed: October 11, 2017
    Publication date: July 2, 2020
    Inventor: Maurizio Paolo Maria FEDERICO